Therefore, studying the regulatory mechanisms of Akt activation is not only important for understanding the role of Akt dysregulation in TNBC, but is also critical to the development of therapeutic strategies against Akt overactivation in breast cancer, especially in TNBC. This evidence concerns the gene AKT1 and breast carcinoma.